Stock Events

Stock Events

Innoviva 

$23.34
40
+$0.32+1.39% Today

Statistics

Day High
23.36
Day Low
22.75
52W High
25.15
52W Low
16.52
Volume
227,016
Avg. Volume
774,970
Mkt Cap
1.73B
P/E Ratio
6.97
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 15
$0.25
Jun 15
$0.25
Mar 15
$0.25
Dec 14
$0.25
Sep 14
$0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.74
0.15
1.05
1.94
Expected EPS
0.39
Actual EPS
N/A

Financials

65.92%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
822.66MRevenue
542.33MNet Income

Analyst Ratings

$37.33Average Price Target
The highest estimate is 46.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INVA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline, partner in respiratory products, also competes in overlapping market segments.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca competes in the respiratory and biopharmaceutical market, similar to Innoviva's interests.
Vertex Pharmaceuticals
VRTX
Mkt Cap111.43B
Vertex Pharmaceuticals is involved in treating cystic fibrosis, a respiratory condition, thus competing with Innoviva.
Biogen
BIIB
Mkt Cap26.03B
Biogen competes in the biopharmaceutical space with a focus on innovative therapies, overlapping with Innoviva's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals competes in the biopharmaceutical field, focusing on innovative drug development like Innoviva.
AMGEN
AMGN
Mkt Cap187.56B
Amgen operates in the biopharmaceutical sector, focusing on innovative treatments, competing with Innoviva.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences competes in the biopharmaceutical market with a focus on innovation and research, similar to Innoviva.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie operates in the biopharmaceutical field, with a focus on research-based pharmaceuticals, competing with Innoviva.
Merck
MRK
Mkt Cap298.84B
Merck & Co. competes in the pharmaceutical and biopharmaceutical sectors, focusing on innovative therapies.
Pfizer
PFE
Mkt Cap161.09B
Pfizer competes across various therapeutic areas, including respiratory diseases, overlapping with Innoviva's market interests.

About

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Show more...
CEO
Mr. Pavel Raifeld C.F.A.
Employees
127
Country
US
ISIN
US45781M1018

Listings

XNAS
US
INVA
F
DE
HVE.F
BOATS
BOATS
INVA.BOATS

0 Comments

Share your thoughts

FAQ

What is Innoviva stock price today?▼
The current price of INVA is $23.34 USD — it has increased by +1.39% in the past 24 hours. Watch Innoviva stock price performance more closely on the chart.
What is Innoviva stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Innoviva stocks are traded under the ticker INVA.
Is Innoviva stock price growing?▼
INVA stock has risen by +0.13% compared to the previous week, the month change is a +5.9% rise, over the last year Innoviva has showed a +33.24% increase.
What is Innoviva market cap?▼
Today Innoviva has the market capitalization of 1.73B
When is the next Innoviva earnings date?▼
Innoviva is going to release the next earnings report on May 13, 2026.
What were Innoviva earnings last quarter?▼
INVA earnings for the last quarter are 1.94 USD per share, whereas the estimation was 0.55 USD resulting in a +252.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Innoviva revenue for the last year?▼
Innoviva revenue for the last year amounts to 822.66M USD.
What is Innoviva net income for the last year?▼
INVA net income for the last year is 542.33M USD.
Does Innoviva pay dividends?▼
Yes, INVA dividends are paid quarterly. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Innoviva have?▼
As of April 07, 2026, the company has 127 employees.
In which sector is Innoviva located?▼
Innoviva operates in the Health Care sector.
When did Innoviva complete a stock split?▼
The last stock split for Innoviva was on June 17, 2013 with a ratio of 1:100.
Where is Innoviva headquartered?▼
Innoviva is headquartered in Burlingame, US.